» Articles » PMID: 33604773

Dystonia Updates: Definition, Nomenclature, Clinical Classification, and Etiology

Overview
Specialties Neurology
Physiology
Date 2021 Feb 19
PMID 33604773
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

A plethora of heterogeneous movement disorders is grouped under the umbrella term dystonia. The clinical presentation ranges from isolated dystonia to multi-systemic disorders where dystonia is only a co-occurring sign. In the past, definitions, nomenclature, and classifications have been repeatedly refined, adapted, and extended to reflect novel findings and increasing knowledge about the clinical, etiologic, and scientific background of dystonia. Currently, dystonia is suggested to be classified according to two axes. The first axis offers precise categories for the clinical presentation grouped into age at onset, body distribution, temporal pattern and associated features. The second, etiologic, axis discriminates pathological findings, as well as inheritance patterns, mode of acquisition, or unknown causality. Furthermore, the recent recommendations regarding terminology and nomenclature of inherited forms of dystonia and related syndromes are illustrated in this article. Harmonized, specific, and internationally widely used classifications provide the basis for future systematic dystonia research, as well as for more personalized patient counseling and treatment approaches.

Citing Articles

Assessment of quality of life in patients with cervical dystonia and hemifacial spasm after botulinum toxin injections.

Elshebawy H, Ramzy G, Salama M, El-Jaafary S Acta Neurol Belg. 2025; .

PMID: 39992580 DOI: 10.1007/s13760-025-02742-x.


Isolated Idiopathic Cervical Dystonia with a Rare Type of Atlantoaxial Dislocation. A Case Report and a Short Literature Review.

Aldakheel D Orthop Res Rev. 2025; 17:55-60.

PMID: 39931215 PMC: 11809398. DOI: 10.2147/ORR.S501294.


The epidemiology and phenomenology of non-antipsychotic-induced dystonia: a hybrid systematic-narrative review.

Kirsten C, Catthoor K, Johan D, Detraux J, De Hert M Eur Psychiatry. 2025; 68(1):e36.

PMID: 39925222 PMC: 11883798. DOI: 10.1192/j.eurpsy.2025.18.


Use of Botulinum Toxin in Upper-Limb Tremor: Systematic Review and Perspectives.

Motavasseli D, Delorme C, Bayle N, Gracies J, Roze E, Baude M Toxins (Basel). 2024; 16(9).

PMID: 39330850 PMC: 11436131. DOI: 10.3390/toxins16090392.


Understanding Clinical Effectiveness and Safety Implications of Botulinum Toxin in Children: A Narrative Review of the Literature.

Crisafulli S, Ciccimarra F, Khan Z, Maccarrone F, Trifiro G Toxins (Basel). 2024; 16(7).

PMID: 39057946 PMC: 11281390. DOI: 10.3390/toxins16070306.


References
1.
Albanese A, Bhatia K, Bressman S, DeLong M, Fahn S, Fung V . Phenomenology and classification of dystonia: a consensus update. Mov Disord. 2013; 28(7):863-73. PMC: 3729880. DOI: 10.1002/mds.25475. View

2.
Berman B, Groth C, Sillau S, Pirio Richardson S, Norris S, Junker J . Risk of spread in adult-onset isolated focal dystonia: a prospective international cohort study. J Neurol Neurosurg Psychiatry. 2019; 91(3):314-320. PMC: 7024047. DOI: 10.1136/jnnp-2019-321794. View

3.
Bressman S, Sabatti C, Raymond D, De Leon D, Klein C, Kramer P . The DYT1 phenotype and guidelines for diagnostic testing. Neurology. 2000; 54(9):1746-52. DOI: 10.1212/wnl.54.9.1746. View

4.
Bull P, Thomas G, Rommens J, FORBES J, Cox D . The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet. 1993; 5(4):327-37. DOI: 10.1038/ng1293-327. View

5.
Charlesworth G, Plagnol V, Holmstrom K, Bras J, Sheerin U, Preza E . Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis. Am J Hum Genet. 2012; 91(6):1041-50. PMC: 3516598. DOI: 10.1016/j.ajhg.2012.10.024. View